检索结果 - Hsiaowei Deng

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
    123I-<i>Meta</i>-Iodobenzylguanidine Scintigraphy for the Detection of Neuroblastoma and Pheochromocytoma: Results of a Meta-Analysis

    123I-<i>Meta</i>-Iodobenzylguanidine Scintigraphy for the Detection of Neuroblastoma and Pheochromocytoma: Results of a Meta-Analysis 由 Arnold Jacobson, Hsiaowei Deng, John Lombard, Harry J. Lessig, Richard R. Black

    出版 2010
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  2. 2
    Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials

    Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials 由 Vlado Perkovic, Dick de Zeeuw, Kenneth W. Mahaffey, Greg Fulcher, Ngozi Erondu, Wayne Shaw, Terrance D. Barrett, Michele A. Weidner‐Wells, Hsiaowei Deng, David R. Matthews, Bruce Neal

    出版 2018
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    Rationale, design and baseline characteristics of the CANagliflozin cardioVascular Assessment Study–Renal (<scp>CANVAS‐R</scp>): A randomized, placebo‐controlled trial

    Rationale, design and baseline characteristics of the CANagliflozin cardioVascular Assessment Study–Renal (<scp>CANVAS‐R</scp>): A randomized, placebo‐controlled trial 由 Bruce Neal, Vlado Perkovic, David R. Matthews, Kenneth W. Mahaffey, Greg Fulcher, Gary Meininger, Ngozi Erondu, Mehul Desai, Wayne Shaw, Frank Vercruysse, Jacqueline Yee, Hsiaowei Deng, Dick de Zeeuw

    出版 2017
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Cardiovascular and Renal Outcomes With Canagliflozin According to Baseline Kidney Function

    Cardiovascular and Renal Outcomes With Canagliflozin According to Baseline Kidney Function 由 Brendon L. Neuen, Toshiaki Ohkuma, Bruce Neal, David R. Matthews, Dick de Zeeuw, Kenneth W. Mahaffey, Greg Fulcher, Mehul Desai, Qiang Li, Hsiaowei Deng, Norm Rosenthal, Meg Jardine, George L. Bakris, Vlado Perkovic

    出版 2018
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    A comprehensive analysis of the effects of rivaroxaban on stroke or transient ischaemic attack in patients with heart failure, coronary artery disease, and sinus rhythm: the COMMANDER HF trial

    A comprehensive analysis of the effects of rivaroxaban on stroke or transient ischaemic attack in patients with heart failure, coronary artery disease, and sinus rhythm: the COMMAN... 由 Mandeep R. Mehra, Muthiah Vaduganathan, Min Fu, João Pedro Ferreira, Stefan D. Anker, John G.F. Cleland, Carolyn S.P. Lam, Dirk J. van Veldhuisen, William M. Byra, Theodore E. Spiro, Hsiaowei Deng, Faı̈ez Zannad, Barry Greenberg

    出版 2019
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    Natriuretic Peptide-Based Inclusion Criteria in a Heart Failure Clinical Trial

    Natriuretic Peptide-Based Inclusion Criteria in a Heart Failure Clinical Trial 由 Jonathan W. Cunningham, João Pedro Ferreira, Hsiaowei Deng, Stefan D. Anker, William M. Byra, John G.F. Cleland, Mihai Gheorghiade, Carolyn S.P. Lam, David La Police, Mandeep R. Mehra, James D. Neaton, Theodore E. Spiro, Dirk J. van Veldhuisen, Barry Greenberg, Faı̈ez Zannad

    出版 2020
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    Association of Rivaroxaban With Thromboembolic Events in Patients With Heart Failure, Coronary Disease, and Sinus Rhythm

    Association of Rivaroxaban With Thromboembolic Events in Patients With Heart Failure, Coronary Disease, and Sinus Rhythm 由 Barry Greenberg, James D. Neaton, Stefan D. Anker, William M. Byra, John G.F. Cleland, Hsiaowei Deng, Min Fu, David A. La Police, Carolyn S.P. Lam, Mandeep R. Mehra, Christopher C. Nessel, Theodore E. Spiro, Dirk J. van Veldhuisen, Catherine M. Vanden Boom, Faı̈ez Zannad

    出版 2019
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    Oral Factor XIa Inhibitor Milvexian After a Recent Acute Coronary Syndrome: Rationale and Design of the Phase 3 (Librexia ACS)

    Oral Factor XIa Inhibitor Milvexian After a Recent Acute Coronary Syndrome: Rationale and Design of the Phase 3 (Librexia ACS) 由 C. Michael Gibson, Maria Cecilia Bahit, Roxana Mehran, Shamir R Mehta, Rasha Al Lamee, Shinya Goto, Jeffrey I. Weitz, Jay Horrow, Elliot S. Barnathan, Robert A. Harrington, Kenneth W. Mahaffey, Siniša Car, Karen S. Pieper, S. Claiborne Johnston, Graeme J. Hankey, Alexei N. Plotnikov, Danshi Li, Hsiaowei Deng, Philippe Gabríel Steg

    出版 2025
    获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: